Gastrointestinal complications of cystic fibrosis
- PMID: 23142604
- DOI: 10.1016/j.cgh.2012.11.006
Gastrointestinal complications of cystic fibrosis
Abstract
The cystic fibrosis transmembrane regulator protein (CFTR) is an ion channel in the apical surface of epithelial membranes that regulates other ion channels. Dysfunction of CFTR leads to the clinical entity of CF when mutations in CFTR are inherited in an autosomal recessive fashion. Although airway obstruction, inflammation, and infection are usually the most serious consequences of CFTR dysfunction because they lead to respiratory failure, CFTR dysfunction affects the intestinal tract and the pancreatic and hepatobiliary ducts in a similar fashion, leading to significant morbidity. This review outlines pathophysiology and common gastrointestinal ailments in the CF population along with current medical and surgical management.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
[Gastrointestinal complications of adult patients with cystic fibrosis].Z Gastroenterol. 1999 Aug;37(8):739-49. Z Gastroenterol. 1999. PMID: 10494610 Review. German.
-
Cholangiocyte biology and cystic fibrosis liver disease.Semin Liver Dis. 2001 Nov;21(4):471-88. doi: 10.1055/s-2001-19030. Semin Liver Dis. 2001. PMID: 11745036 Review.
-
[Early bronchial inflammation in cystic fibrosis].J Soc Biol. 2002;196(1):29-35. J Soc Biol. 2002. PMID: 12134630 Review. French.
-
Gastrointestinal manifestations in cystic fibrosis.Eur J Gastroenterol Hepatol. 1996 Aug;8(8):731-8. Eur J Gastroenterol Hepatol. 1996. PMID: 8864667 Review.
-
Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.JOP. 2001 Jul;2(4 Suppl):212-8. JOP. 2001. PMID: 11875262 Review.
Cited by
-
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI.J Cyst Fibros. 2023 Mar;22(2):282-289. doi: 10.1016/j.jcf.2022.10.003. Epub 2022 Oct 21. J Cyst Fibros. 2023. PMID: 36280527 Free PMC article.
-
Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert's syndrome.BMC Pulm Med. 2024 Jul 1;24(1):307. doi: 10.1186/s12890-024-03114-6. BMC Pulm Med. 2024. PMID: 38956524 Free PMC article.
-
What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?Nutrients. 2022 Jan 22;14(3):480. doi: 10.3390/nu14030480. Nutrients. 2022. PMID: 35276841 Free PMC article. Review.
-
Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.World J Biol Chem. 2014 May 26;5(2):180-203. doi: 10.4331/wjbc.v5.i2.180. World J Biol Chem. 2014. PMID: 24921008 Free PMC article. Review.
-
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.Am J Respir Crit Care Med. 2014 Jul 15;190(2):175-84. doi: 10.1164/rccm.201404-0703OC. Am J Respir Crit Care Med. 2014. PMID: 24927234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical